ANXIETY DISORDERS IN CLINICAL PRACTICE

Abstract

Background: Anxiety disorders are highly prevalent in the community and are associated with an often underestimated degree of impairment. Psychological treatments are regarded as first line, and advances in knowledge around cognitive maintaining factors for anxiety have improved treatment outcomes. Simultaneously, the role and effective use of pharmacological interventions has become more clearly established. Objective(s): To provide an update on key features of anxiety disorders relevant to clinical practice and to provide clinically relevant information about the causes and effective treatment of anxiety disorders. Method(s): As far as practicable, the presenters aim to tailor the material to participants, who are invited to submit topics they would like to be addressed: this can be done at the start of the session or at any time prior by email. Relevant summaries of the literature and clinical practice guidelines will be presented. Case material will be employed to illustrate aspects of the topic and will include use of online voting technology - participants are encouraged to bring their smart devices. Role play of techniques may be employed if relevant or requested. Finding(s): An accurate diagnosis and assessment of initiating and especially maintaining factors in anxiety disorders and relevant comorbidities is important. Psychological treatments are first line and have the best long-term outcome. Pharmacotherapy can be effective and guidelines for use in anxiety disorders differ somewhat from depression. Novel treatments and treatment modalities show promise. Conclusion(s): Anxiety disorders are satisfying to treat because people get better! Psychiatrists can update their knowledge and skills to ensure effective treatment.